• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Anthem, Apple to launch asthma study

Anthem, Apple to launch asthma study

September 16, 2020 By Sean Whooley

Anthem (NYSE:ANTM) announced today that it is collaborating with Apple (NSDQ:AAPL) on a study using smart devices to manage asthma.

Indianapolis-based Anthem and Apple are planning on examining how the use of everyday devices like the Apple Watch and iPhone can help individuals with asthma better self-manage their condition in search of improved clinical outcomes, according to a news release.

The University of California, Irvine is conducting the virtual study, which Anthem designed in collaboration with Apple. CareEvolution is the study technology partner responsible for building the app and enabling the collection of data from the study.

Participants from Anthem-affiliated health plans who are clinically diagnosed with asthma will be enrolled in the two-year, randomized, controlled study and will receive a Beddit sleep monitor and an Apple Watch. The active group in the study will have access to the digital asthma tool with daily symptom and trigger tracking with signals including activity, heart rate and blood oxygen, among other metrics.

The primary goal of the study is investigating clinical changes in outcomes associated with the use of the digital offerings and to see if the data collected from those devices can help predict asthma exacerbation or serve as potential biomarkers of asthma control.

Anthem and Apple said the study offers complete control over data to the participants to ensure privacy, as the data will be stored on the user’s device and shared through a direct, encrypted connection with CareEvolution so that it can be collected for the study.

“As part of our mission of improving people’s lives, we are making it easier for consumers to proactively manage their health through our digital-first approach to delivering healthcare solutions and services,” Anthem chief digital officer Rajeev Ronanki said in the release. “Millions of Americans are struggling with their asthma condition each day and we’re thrilled to collaborate with UCI, Apple and CareEvolution on studying new solutions.”

“The digital asthma study brings together Apple Watch’s innovative technology with an engaging app-based self-management experience to investigate how consumers can better manage and control a prevalent condition,” Apple head of health strategic initiatives Myoung Cha said. “We hope this study can help the medical community produce new insights about asthma control and can identify effective digital tools that can help empower people around the world to better manage their condition.”

Filed Under: Big Data, Clinical Trials, Health Technology, Respiratory, Software / IT Tagged With: Anthem Inc., Apple, CareEvolution

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy